Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
about
Disruption of a novel imprinted zinc-finger gene, ZNF215, in Beckwith-Wiedemann syndromeBone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factorA new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiationInduction of p57(KIP2) expression by p73beta.Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genesPAX3-FOXO1 fusion gene in rhabdomyosarcomaPostnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinasesCaspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cellsSilencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndromeSuppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigenCellular Response upon Stress: p57 Contribution to the Final OutcomeMolecular basis of cleft palates in micePP2A: more than a reset switch to activate pRB proteins during the cell cycle and in response to signaling cues.Arginylation-dependent neural crest cell migration is essential for mouse developmentGlypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndromeStabilization of MyoD by direct binding to p57(Kip2)The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domainp57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleusInactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumorsIdentification and functional characterization of an intragenic DNA binding site for the spumaretroviral trans-activator in the human p57Kip2 geneAn important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferationHypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survivalTbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1bCritical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossificationFetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndromep57Kip2 expression is enhanced during mid-cardiac murine development and is restricted to trabecular myocardiumCooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and developmentThe imprinted Phlda2 gene regulates extraembryonic energy storesMyoD regulates p57kip2 expression by interacting with a distant cis-element and modifying a higher order chromatin structureBMP10 is essential for maintaining cardiac growth during murine cardiogenesisp57(Kip2) cooperates with Nurr1 in developing dopamine cellsCommon and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse modelImpaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2Global increase in replication fork speed during a p57KIP2-regulated erythroid cell fate switchBehavioural abnormalities in a novel mouse model for Silver Russell Syndrome.A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis.Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescenceCdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7.
P2860
Q22253880-07C7DD51-9781-4AC8-94FC-C6F81E678652Q24299331-19AAB75D-5C18-4DAA-81E0-B2C52B6AF0BDQ24305315-30493BCA-FB1D-4A88-B257-B92B7AEEB3FCQ24317543-3FB4DB64-CC65-46DD-B562-0FDF1D9188C1Q24531472-E1D1A4A9-1821-4E65-BBE6-E86BAEB58E97Q24546155-F7705F99-2F1C-4949-BFEE-25F5C3563DBCQ24646520-56E5266E-EE30-4B93-948D-A7F3836CA3BCQ24649057-623A93D4-2941-46C0-B1CA-CDAFDC96894DQ24656695-F0C0CD0C-5D9A-42CC-95C0-55B95F1E8514Q24678326-A6422CBA-F21B-4F0C-83BE-8EF75A347768Q24682776-B0E8521F-CF49-4A4E-AC4D-93D8BF88B211Q26778537-D4824BB3-E1F3-475B-8E0F-AC669B18393BQ26795762-79DF20F3-A1C8-45D1-8074-BBEFA578AADCQ26823704-B8DAE4CA-5578-4B5E-A3A7-4DD627B35C05Q27348001-28FFC672-894F-4080-8252-5C6A9542E349Q28139404-D5A15A21-44EF-49B9-AC18-664E5595013DQ28141776-1AD745A6-6440-4EF5-8B28-565128563FE1Q28204250-20FB7158-7016-4777-A6F9-F0FA3252662FQ28207713-8B969897-7C77-4100-A852-14BC2FC12757Q28215348-2E257BEC-EAFA-4E8B-AC31-ABA1EB516871Q28216836-BC0B3F2F-AB5A-4B9F-B53A-0B017C0091C5Q28349872-3489FEE9-F4BC-4758-9D37-9FC4A6B137BFQ28363133-E8D3E5C8-AD94-4656-BBB7-BD26A9413DB9Q28485157-519D1EBE-AB9C-4CC1-B9CE-98613476CFAFQ28505336-1A856E4C-E954-454E-AEB5-5464E9D68D37Q28505485-8F1DC342-A60E-4B67-BDEB-F4AAFDD8BE3EQ28507727-0047F222-040A-4862-A88F-3A1D985D9B6FQ28512118-D5EB5D78-5C71-488E-8437-E0DCD560C79DQ28512597-BB28B4B0-316A-444E-8C40-A700FC6BDCC3Q28512786-2F2758F2-E269-4CB7-8280-569D2C496BDCQ28586844-1CF8DE5A-9612-4EF8-BCD5-4536F91AE470Q28587845-7DA60418-1E9B-45ED-B082-8E1F72ADEA73Q28588011-64E3D830-39C2-47B5-91B4-A3E682E53B9EQ28589342-5CDD64CC-C7E8-4672-803D-D520C5F6AFF4Q28910370-99F64C6F-EE5A-4626-BCE9-1B512ADD5AD4Q30352573-EF78BD55-84B9-4488-A747-154EA317170FQ30356916-C50A75A7-53FC-4414-8C48-653D0967BFE6Q30465746-236C86EB-8EF3-4CD9-960A-45937188FA2DQ33181041-2AB93A23-046C-4B24-9A72-3029B99DC6A2Q33285306-CBC54E45-C069-4889-B798-662EE9E5EA70
P2860
Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Ablation of the CDK inhibitor ...... tion during mouse development.
@en
Ablation of the CDK inhibitor ...... tion during mouse development.
@nl
type
label
Ablation of the CDK inhibitor ...... tion during mouse development.
@en
Ablation of the CDK inhibitor ...... tion during mouse development.
@nl
prefLabel
Ablation of the CDK inhibitor ...... tion during mouse development.
@en
Ablation of the CDK inhibitor ...... tion during mouse development.
@nl
P2093
P356
P1433
P1476
Ablation of the CDK inhibitor ...... ation during mouse development
@en
P2093
P304
P356
10.1101/GAD.11.8.973
P577
1997-04-01T00:00:00Z